Leerink Partners Cuts CVS Health Price Target to $112 a Share
Leerink Partners lowered its price target for CVS Health to $112 a share from $119, Dow Jones Newswires reported, citing Benzinga analyst data.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Dow Jones Newswires reported that Leerink Partners lowered its price target for CVS Health to $112 a share from $119.
The ratings action was listed on Benzinga’s analyst-ratings page. The information was published on October 12, 2026.
why it matters
The revised target reflects a change in the analyst’s valuation of CVS Health and may be considered by investors assessing the company’s shares.
instruments
sources
- CVS Health Price Target Cut to $112.00/Share From $119.00 by Leerink Partners — Dow Jones Newswires, 12 October 2026 at 13:09 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗